LINDSEY SHAW: Open Payments
NPI 1518323542 · ROGERS, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,131 in 51 payments from 17 companies in 2025. Trend: 2023 $704 · 2024 $1,059 · 2025 $1,131
Food & beverage: $1,131
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 4 | $176 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $99 |
| GENZYME CORPORATION | 4 | $97 |
| Grifols USA, LLC | 3 | $82 |
| United Therapeutics Corporation | 3 | $80 |
| Merck Sharp & Dohme LLC | 3 | $77 |
| Electromed, Inc. | 6 | $72 |
| AstraZeneca Pharmaceuticals LP | 4 | $67 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $66 |
| Mallinckrodt Hospital Products Inc. | 2 | $66 |
Products named: DUPIXENT, Prolastin-C Liquid, Tyvaso, TEZSPIRE, SMARTVEST, GLASSIA, ACTHAR, WINREVAIR.
Industry payments across AR — which companies pay providers there.
